文献速递其他结缔组织病

肺气肿升高DETECT评分:对系统性硬化症肺动脉高压筛查与诊断的影响

Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在550例系统性硬化症患者中,肺气肿和合并肺纤维化与肺气肿(CPFE)患者的DETECT评分更高且更常超过右心导管检查转诊阈值,但肺气肿和CPFE均与DETECT假阳性无关,支持DETECT算法在这些亚组中的有效性。

要点

  • 肺气肿和CPFE患者DETECT评分更高且平均超过右心导管转诊阈值。
  • 校正后肺气肿和CPFE预测DETECT评分阳性,而间质性肺病(ILD)不预测。
  • 肺气肿和CPFE均与DETECT假阳性无关联,支持算法有效性。

核心结论

  • 在系统性硬化症中,CPFE和肺气肿与更高且更常阳性的DETECT评分相关。
  • CPFE和肺气肿均与DETECT假阳性结果无关,数据支持DETECT算法在这些亚组中的有效性。

研究设计与样本

  • 来自转诊中心的系统性硬化症患者,需有胸部断层图像以识别肺气肿或间质性肺病,并有数据计算DETECT评分。
  • 基线访视设为有可用信息的首次访视,基线时任何形式的肺动脉高压患者被排除。
  • 采用回归模型校正选定协变量,检验CPFE(及分别的ILD和肺气肿)与DETECT评分、DETECT评分阳性及假阳性的关联。

主要发现

  • 550例合格病例中,ILD检出232例(42%),肺气肿检出59例(11%),CPFE患病率为7%。
  • 肺气肿和CPFE患者的DETECT评分更高,且平均超过转诊右心导管检查的阈值。
  • 校正后,肺气肿和CPFE均预测DETECT评分阳性,而ILD不预测。
  • CPFE和肺气肿均与DETECT假阳性评分无关联。

关键数值与推荐

  • 550例合格病例中ILD 232例(42%)、肺气肿59例(11%)、CPFE患病率7%。
  • 肺气肿和CPFE患者DETECT评分更高且平均超过右心导管转诊阈值。
  • 校正后肺气肿和CPFE预测DETECT评分阳性,ILD不预测。
  • CPFE和肺气肿与DETECT假阳性无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Combined pulmonary fibrosis and emphysema (CPFE) predicts unfavourable outcomes in systemic sclerosis (SSc). CPFE and emphysema are associated with pulmonary function tests (PFTs) abnormalities. As screening algorithms for pulmonary hypertension include PFTs, we aimed to assess whether CPFE and emphysema affect the performance of the DETECT algorithm to select patients for right-heart catheterization (RHC). METHODS: SSc patients from our referral centre, with available chest tomography images to identify emphysema or interstitial lung disease (ILD) and data to calculate the DETECT score were included. Baseline visit was set as the first visit with available information. Patients with any form of pulmonary hypertension at baseline were excluded. We tested the association of CPFE (and ILD and emphysema separately) with the DETECT score, DETECT score positivity and false positivity, using regression models adjusted for selected covariates. RESULTS: Among 550 eligible cases, ILD was detected in 232 (42%) and emphysema in 59 (11%) patients, resulting in a 7% prevalence of CPFE. The DETECT score was higher and on average above the threshold for referral to RHC in emphysema and CPFE patients. After adjustment, both emphysema and CPFE predicted positive DETECT scores, while ILD did not. Nevertheless, we found no association between CPFE nor emphysema with false-positive DETECT scores. CONCLUSION: In SSc, CPFE and emphysema are associated with a higher and more frequently positive DETECT score. As neither CPFE nor emphysema were associated with false-positive DETECT results, our data also support the validity of the DETECT algorithm in these SSc subgroups.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Sauer GM, Käs F, Mihai CM, et al. Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis. Rheumatology (Oxford). 2025. PMID: 40748717. doi:10.1093/rheumatology/keaf410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。